Terms: = Ovarian cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Treatment
56 results:
1. Curcumin modulates cell type-specific miRNA networks to induce cytotoxicity in ovarian cancer cells.
Ravindran F; Mhatre A; Koroth J; Narayan S; Choudhary B
Life Sci; 2023 Dec; 334():122224. PubMed ID: 38084671
[TBL] [Abstract] [Full Text] [Related]
2. Scoulerine promotes cytotoxicity and attenuates stemness in ovarian cancer by targeting PI3K/AKT/mTOR axis.
Wang F; Zhang Y; Pang R; Shi S; Wang R
Acta Pharm; 2023 Sep; 73(3):475-488. PubMed ID: 37708956
[TBL] [Abstract] [Full Text] [Related]
3. cancer Stem Cell Markers-Clinical Relevance and Prognostic Value in High-Grade Serous ovarian cancer (HGSOC) Based on The cancer Genome Atlas Analysis.
Iżycka N; Zaborowski MP; Ciecierski Ł; Jaz K; Szubert S; Miedziarek C; Rezler M; Piątek-Bajan K; Synakiewicz A; Jankowska A; Figlerowicz M; Sterzyńska K; Nowak-Markwitz E
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628927
[TBL] [Abstract] [Full Text] [Related]
4. HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis.
Di Agostino S; Canu V; Donzelli S; Pulito C; Sacconi A; Ganci F; Valenti F; Goeman F; Scalera S; Rollo F; Bagnato A; Diodoro MG; Vizza E; Carosi M; Rufini B; Federici O; Giofrè M; Carboni F; Muti P; Ciliberto G; Strano S; Valle M; Blandino G
Cell Death Dis; 2023 Aug; 14(8):535. PubMed ID: 37598177
[TBL] [Abstract] [Full Text] [Related]
5. Regulation of self-renewal in ovarian cancer stem cells by fructose via chaperone-mediated autophagy.
Sohn EJ; Kim JH; Oh SO; Kim JY
Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166723. PubMed ID: 37087023
[TBL] [Abstract] [Full Text] [Related]
6. Low-dose BPA and its substitute BPS promote ovarian cancer cell stemness via a non-canonical PINK1/p53 mitophagic signaling.
Yuan X; Chen K; Zheng F; Xu S; Li Y; Wang Y; Ni H; Wang F; Cui Z; Qin Y; Xia D; Wu Y
J Hazard Mater; 2023 Jun; 452():131288. PubMed ID: 36989771
[TBL] [Abstract] [Full Text] [Related]
7. Anti-ovarian cancer actions and pharmacological targets of plumbagin.
Liang K; Pan X; Chen Y; Huang S
Naunyn Schmiedebergs Arch Pharmacol; 2023 Jun; 396(6):1205-1210. PubMed ID: 36692828
[TBL] [Abstract] [Full Text] [Related]
8. NANOG regulates epithelial-mesenchymal transition via AMPK/mTOR signalling pathway in ovarian cancer SKOV-3 and A2780 cells.
Yun H; Han GH; Kim J; Chung JY; Kim JH; Cho H
J Cell Mol Med; 2022 Oct; 26(20):5277-5291. PubMed ID: 36114703
[TBL] [Abstract] [Full Text] [Related]
9. Therapeutic Targeting of ovarian cancer Stem Cells Using Estrogen Receptor Beta Agonist.
He Y; Alejo S; Venkata PP; Johnson JD; Loeffel I; Pratap UP; Zou Y; Lai Z; Tekmal RR; Kost ER; Sareddy GR
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806169
[TBL] [Abstract] [Full Text] [Related]
10. PIK3R3, a regulatory subunit of PI3K, modulates ovarian cancer stem cells and ovarian cancer development and progression by integrative analysis.
Sohn EJ
BMC Cancer; 2022 Jun; 22(1):708. PubMed ID: 35761259
[TBL] [Abstract] [Full Text] [Related]
11. Endogenous, tissue-resident stem/progenitor cells in gonads and bone marrow express FSHR and respond to FSH via FSHR-3.
Bhartiya D; Patel H; Kaushik A; Singh P; Sharma D
J Ovarian Res; 2021 Oct; 14(1):145. PubMed ID: 34717703
[TBL] [Abstract] [Full Text] [Related]
12. Development and in vitro characterisation of an induced pluripotent stem cell model of ovarian cancer.
Bindhya S; Sidhanth C; Krishnapriya S; Garg M; Ganesan TS
Int J Biochem Cell Biol; 2021 Sep; 138():106051. PubMed ID: 34343671
[TBL] [Abstract] [Full Text] [Related]
13. Chemokine CCL20 promotes the paclitaxel resistance of CD44
Chen M; Su J; Feng C; Liu Y; Zhao L; Tian Y
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278466
[TBL] [Abstract] [Full Text] [Related]
14. MET Expression and cancer Stem Cell Networks Impact Outcome in High-Grade Serous ovarian cancer.
Bååth M; Jönsson JM; Westbom Fremer S; Martín de la Fuente L; Tran L; Malander S; Kannisto P; Måsbäck A; Honeth G; Hedenfalk I
Genes (Basel); 2021 May; 12(5):. PubMed ID: 34069138
[TBL] [Abstract] [Full Text] [Related]
15. EIF5A2 enhances stemness of epithelial ovarian cancer cells via a E2F1/KLF4 axis.
Wang K; Wang Y; Wang Y; Liu S; Wang C; Zhang S; Zhang T; Yang X
Stem Cell Res Ther; 2021 Mar; 12(1):186. PubMed ID: 33726845
[TBL] [Abstract] [Full Text] [Related]
16. iPSC-Derived Hereditary Breast cancer Model Reveals the
Portier L; Desterke C; Chaker D; Oudrhiri N; Asgarova A; Dkhissi F; Turhan AG; Bennaceur-Griscelli A; Griscelli F
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513753
[TBL] [Abstract] [Full Text] [Related]
17. Characteristics of CD133-Sustained Chemoresistant cancer Stem-Like Cells in Human ovarian Carcinoma.
Liu CL; Chen YJ; Fan MH; Liao YJ; Mao TL
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899775
[TBL] [Abstract] [Full Text] [Related]
18. A novel c-Kit/phospho-prohibitin axis enhances ovarian cancer stemness and chemoresistance via Notch3-PBX1 and β-catenin-ABCG2 signaling.
Fang CH; Lin YT; Liang CM; Liang SM
J Biomed Sci; 2020 Mar; 27(1):42. PubMed ID: 32169072
[TBL] [Abstract] [Full Text] [Related]
19. Mutually exclusive antiproliferative effect of cell line-specific HOX inhibition in epithelial ovarian cancer cell lines: SKOV-3 vs RMUG-S.
Kim M; Suh DH; Choi JY; Lee S; Bae JR; Kim K; No JH; Kim YB
J Cell Mol Med; 2020 Mar; 24(5):3246-3251. PubMed ID: 31970886
[TBL] [Abstract] [Full Text] [Related]
20. The human amniotic fluid mesenchymal stem cells therapy on, SKOV3, ovarian cancer cell line.
Gholizadeh-Ghaleh Aziz S; Fardyazar Z; Pashaiasl M
Mol Genet Genomic Med; 2019 Jul; 7(7):e00726. PubMed ID: 31111674
[TBL] [Abstract] [Full Text] [Related]
[Next]
